Integrated Filing — IndAS

General information about company
Scrip Code	500114
NSE Symbol	TITAN
MSEI Symbol	NOTLISTED
ISIN	INE280A01028
Name of company	TITAN COMPANY LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	08-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	21-Apr-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Multi segment
Description of single segment
Start date and time of board meeting	08-May-2025   14:00:00
End date and time of board meeting	08-May-2025   16:55:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	149160000000	604560000000
	Other income	1160000000	4860000000
	Total income	150320000000	609420000000
2	Expenses
(a)	Cost of materials consumed	144550000000	477080000000
(b)	Purchases of stock-in-trade	20360000000	75630000000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-49760000000	-78150000000
(d)	Employee benefit expense	5590000000	21560000000
(e)	Finance costs	2520000000	9530000000
(f)	Depreciation, depletion and amortisation expense	1830000000	6930000000
(f)	Other Expenses
1	Advertising	3200000000	13080000000
2	Other expenses	9850000000	38420000000
	Total other expenses	13050000000	51500000000
	Total expenses	138140000000	564080000000
3	Total profit before exceptional items and tax	12180000000	45340000000
4	Exceptional items	0	0
5	Total profit before tax	12180000000	45340000000
6	Tax expense
7	Current tax	3260000000	11830000000
8	Deferred tax	210000000	150000000
9	Total tax expenses	3470000000	11980000000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	8710000000	33360000000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	10000000
16	Total profit (loss) for period	8710000000	33370000000
17	Other comprehensive income net of taxes	-270000000	-1360000000
18	Total Comprehensive Income for the period	8440000000	32010000000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent	8710000000	33370000000
	Total profit or loss, attributable to non-controlling interests	0	0
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	-270000000	-1360000000
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	0	0
21	Details of equity share capital
	Paid-up equity share capital	887800000	887800000
	Face value of equity share capital	1	1
27	Details of debt securities
22	Reserves excluding revaluation reserve		31260000000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	9.82	37.62
	Diluted earnings (loss) per share from continuing operations	9.82	37.61
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	9.82	37.62
	Diluted earnings (loss) per share from continuing and discontinued operations	9.82	37.61
24	Debt equity ratio	0.0112	0.0112
25	Debt service coverage ratio	0.0169	0.0247
26	Interest service coverage ratio	0.1009	0.0923
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	18540000000
	Capital work-in-progress	930000000
	Investment property	10000000
	Goodwill	1230000000
	Other intangible assets	3100000000
	Intangible assets under development	120000000
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	6510000000
	Trade receivables, non-current	0
	Loans, non-current	620000000
	Other non-current financial assets	8680000000
	Total non-current financial assets	15810000000
	Deferred tax assets (net)	1700000000
	Other non-current assets	20690000000
	Total non-current assets	62130000000
2	Current assets
	Inventories	281840000000
	Current financial asset
	Current investments	13370000000
	Trade receivables, current	10680000000
	Cash and cash equivalents	4070000000
	Bank balance other than cash and cash equivalents	11770000000
	Loans, current	440000000
	Other current financial assets	2600000000
	Total current financial assets	42930000000
	Current tax assets (net)	0
	Other current assets	19570000000
	Total current assets	344340000000
3	Non-current assets classified as held for sale
4	Regulatory deferral account debit balances and related deferred tax Assets
	Total assets	406470000000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	890000000
	Other equity	115350000000
	Total equity attributable to owners of parent	116240000000
	Non controlling interest	0
	Total equity	116240000000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	5950000000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	60000000
	Total non-current financial liabilities	6010000000
	Provisions, non-current	2990000000
	Deferred tax liabilities (net)	20000000
	Deferred government grants, Non-current	0
	Other non-current liabilities	23280000000
	Total non-current liabilities	32300000000
	Current liabilities
	Current financial liabilities
	Borrowings, current	96910000000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	2170000000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	17460000000
	Total Trade payable	19630000000
	Other current financial liabilities	13300000000
	Total current financial liabilities	129840000000
	Other current liabilities	126140000000
	Provisions, current	1550000000
	Current tax liabilities (Net)	400000000
	Deferred government grants, Current
	Total current liabilities	257930000000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	290230000000
	Total equity and liabilites	406470000000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
1	Watches and Wearables	11340000000	45980000000
2	Jewellery	132530000000	539660000000
3	Eyecare	1930000000	8010000000
4	Others	3850000000	12750000000
5	Corporate (unallocated)	670000000	3020000000
	Total Segment Revenue	150320000000	609420000000
	Less: Inter segment revenue
	Revenue from operations	150320000000	609420000000
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
1	Watches and Wearables	1330000000	5480000000
2	Jewellery	13330000000	48990000000
3	Eyecare	190000000	800000000
4	Others	260000000	80000000
5	Corporate (unallocated)	-410000000	-470000000
	Total Profit before tax	14700000000	54880000000
	i. Finance cost	2520000000	2520000000
	ii. Other Unallocable Expenditure net off Unallocable income	0	0
	Profit before tax	12180000000	45350000000
3	(Segment Asset - Segment Liabilities)
	Segment Asset
1	Watches and Wearables	42080000000	42080000000
2	Jewellery	302190000000	302190000000
3	Eyecare	6670000000	6670000000
4	Others	14460000000	14460000000
5	Corporate (unallocated)	41070000000	41070000000
	Total Segment Asset	406470000000	406470000000
	Un-allocable Assets	0	0
	Net Segment Asset	406470000000	406470000000
4	Segment Liabilities
	Segment Liabilities
1	Watches and Wearables	12250000000	12250000000
2	Jewellery	188200000000	188200000000
3	Eyecare	4020000000	4020000000
4	Others	6710000000	6710000000
5	Corporate (unallocated)	7050000000	7050000000
	Total Segment Liabilities	218230000000	218230000000
	Un-allocable Liabilities	0	0
	Net Segment Liabilities	218230000000	218230000000
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Remeasurement of employee defined benefit plans	-400000000	-270000000
2	Fair value changes on equity investments through OCI	30000000	-1110000000
	Total Amount of items that will not be reclassified to profit and loss	-370000000	-1380000000
2	Income tax relating to items that will not be reclassified to profit or loss	-100000000	-60000000
3	Amount of items that will be reclassified to profit and loss
1	Exchange differences in translating the financial statements of foreign operation	0	-50000000
	Total Amount of items that will be reclassified to profit and loss	0	-50000000
4	Income tax relating to items that will be reclassified to profit or loss	0	-10000000
5	Total Other comprehensive income	-270000000	-1360000000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Consolidated
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			45340000000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			9530000000
	Adjustments for decrease (increase) in inventories			-90720000000
	Adjustments for decrease (increase) in trade receivables, current			-950000000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-2240000000
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			600000000
	Adjustments for other financial assets, current			0
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			30340000000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			3500000000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			6930000000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			520000000
	Adjustments for provisions, non-current			270000000
	Adjustments for other financial liabilities, current			6630000000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			90000000
	Adjustments for dividend income			0
	Adjustments for interest income			0
	Adjustments for share-based payments			130000000
	Adjustments for fair value losses (gains)			-10000000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-1670000000
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			10000000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			-37040000000
	Net cash flows from (used in) operations			8300000000
	Dividends received			0
	Interest paid			0
	Interest received			-2880000000
	Income taxes paid (refund)			10900000000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			-5480000000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			183980000000
	Other cash payments to acquire equity or debt instruments of other entities			177970000000
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			0
	Purchase of property, plant and equipment			4940000000
	Proceeds from sales of investment property			240000000
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			2880000000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			1320000000
	Net cash flows from (used in) investing activities	5510000000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			60000000
	Payments of other equity instruments			10000000
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			25990000000
	Repayments of borrowings			3780000000
	Payments of lease liabilities			7000000000
	Dividends paid			9760000000
	Interest paid			5380000000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			70000000
	Net cash flows from (used in) financing activities			70000000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			100000000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			100000000
	Cash and cash equivalents cash flow statement at beginning of period			4100000000
	Cash and cash equivalents cash flow statement at end of period			4200000000